9.300
+10,71%
2026-10-16
Fundamental Analysis
0 / 100—Rubric: Manufacturing
Not rated — insufficient or unsupported data
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | — | — | 0 / 3 | — | — | — | — | 3.39 | 25.06 | 635 | — | 5,8 | — | 25.06 | 7.39 | +239,2% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 9.300 (close price on 2026-10-16)EPS (TTM): 371,1
Financial charts
1.Revenue & growth
VND bn635Q2/26
1.Revenue & growth
VND bn635Q2/26
2.Profit & growth
VND bn5,77Q2/26
3.Profit mix (Penman)
This company reports nothing on these lines.
4.Margins & cost structure
This company reports nothing on these lines.
5.Returns & cash cycle
This company reports nothing on these lines.
6.Earnings quality & cash
This company reports nothing on these lines.
7.Asset structure
VND bn1.411Q2/26
8.Funding & debt health
VND bn · times1.411Q2/26
9.Revenue backlog
VND bn61,7Q2/26
10.Valuation
times · %9,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %330Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26